60 Is this the beginning of the end for warfarin?

Introduction: The European Society of Cardiology guidelines on the management of atrial fibrillation (AF) advocate the use of direct oral anticoagulants (DOACs) in preference to warfarin. DOACs are also licensed for the treatment of pulmonary embolus and deep venous thrombosis. DOACs are easier to use, result in fewer intracranial haemorrhages and are just as efficacious, if not more so, in reducing the incidence of ischaemic strokes as warfarin.
Source: Europace - Category: Cardiology Source Type: research